CX Institutional’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,693
| Closed | -$279K | – | 1605 |
|
|
2026
Q1 | $279K | Buy |
3,693
+77
| +2% | +$5.79K | 0.01% | 627 |
|
|
2025
Q4 | $269K | Buy |
3,616
+171
| +5% | +$12.5K | 0.01% | 612 |
|
|
2025
Q3 | $233K | Sell |
3,445
-248
| -7% | -$16.5K | 0.01% | 645 |
|
|
2025
Q2 | $241K | Buy |
3,693
+513
| +16% | +$30.7K | 0.01% | 565 |
|
|
2025
Q1 | $196K | Buy |
+3,180
| New | +$211K | 0.01% | 606 |
|
|
2022
Q3 | – | Sell |
-694
| Closed | -$48K | – | 762 |
|
|
2022
Q2 | $48K | Buy |
+694
| New | +$51.5K | ﹤0.01% | 681 |
|
|
2021
Q4 | – | Sell |
-642
| Closed | -$47K | – | 590 |
|
|
2021
Q3 | $47K | Buy |
642
+40
| +7% | +$3K | ﹤0.01% | 593 |
|
|
2021
Q2 | $40K | Buy |
602
+166
| +38% | +$11.1K | ﹤0.01% | 603 |
|
|
2021
Q1 | $32K | Buy |
436
+69
| +19% | +$5.24K | ﹤0.01% | 581 |
|
|
2020
Q4 | $27K | Buy |
367
+35
| +11% | +$2.47K | ﹤0.01% | 554 |
|
|
2020
Q3 | $22K | Buy |
332
+122
| +58% | +$7.72K | ﹤0.01% | 525 |
|
|
2020
Q2 | $12K | Buy |
210
+134
| +176% | +$6.58K | ﹤0.01% | 535 |
|
|
2020
Q1 | $3K | Buy |
76
+7
| +10% | +$333 | ﹤0.01% | 612 |
|
|
2019
Q4 | $4K | Hold |
69
| – | – | ﹤0.01% | 586 |
|
|
2019
Q3 | $3K | Buy |
+69
| New | +$3.4K | ﹤0.01% | 671 |
|
|
2019
Q2 | – | Sell |
-62
| Closed | -$3K | – | 968 |
|
|
2019
Q1 | $3K | Buy |
+62
| New | +$2.8K | ﹤0.01% | 628 |
|
Other funds holding HOLX
CX Institutional's HOLX Position: Q2 2026 in Review
CX Institutional sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,693 shares — an estimated $279K sold.
CX Institutional first reported a position in HOLX in Q1 2019 and held it in 16 quarters. The position peaked at $279K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- CX Institutional reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- CX Institutional sold 3,693 Hologic shares in Q2 2026, an estimated $279K.
- CX Institutional first reported a position in Hologic in Q1 2019 and held it in 16 quarters.
- CX Institutional's Hologic position peaked at $279K in Q1 2026.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.